BI

BIOLASE IncNASDAQ BIOL Stock Report

Last reporting period 31 Mar, 2024

Updated 22 Nov, 2024

Last price

Market cap $B

0.002

Micro

Exchange

XNAS - Nasdaq

BIOL Stock Analysis

BI

Uncovered

BIOLASE Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-34/100

Low score

Market cap $B

0.002

Dividend yield

Shares outstanding

24.174 B

BIOLASE, Inc. is a provider of advanced laser systems for the dental industry. The Company develops, manufactures, markets and sells laser systems, which provides helps to dental practitioners and their patients. The Company’s systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons and other dental specialists to perform a range of dental procedures, including cosmetic, restorative and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft tissue) systems. Its Waterlase brand uses a patented combination of water and laser energy and performs using drills, scalpels and other traditional dental instruments for cutting soft and hard tissue. It offers its diode laser systems to perform soft tissue, pain therapy and cosmetic procedures, including teeth whitening. It has approximately 301 issued and 38 pending United States and international patents.

View Section: Eyestock Rating